Often associated with elevated serum IgG4
Similar fibroinflammatory process often affects other organs such as bile ducts, salivary glands, retroperitoneum, and lymph nodes
•
Associated with many other autoimmune diseases; ANA often positive
Clinical Issues
•
Nonspecific: Jaundice, weight loss, vague abdominal pain
•
Elevated serum IgG4 (not invariably present, and not diagnostic of autoimmune pancreatitis)
More common in type 1 than type 2 AIP
•
Steroid therapy is usually very effective
Recurrence reported in 6-26%
•
Often mimics pancreatic adenocarcinoma clinically and radiographically
Macroscopic
•
Enlarged, firm pancreas ± mass lesion; may mimic adenocarcinoma
Usually head is most prominently involved
•
Stenosis of pancreatic duct and intrapancreatic common bile duct are common
Microscopic
•
Dense, lymphoplasmacytic infiltration centered around main and interlobular pancreatic ducts
•
Periductal, lobular, and perilobular fibrosis
•
Obliterative phlebitis and venulitis
Type 1: Lobular and interlobular distribution, obliterative phlebitis, numerous IgG4(+) plasma cells
Type 2: Duct-centric distribution, granulocytic epithelial lesions, only rare IgG(+) plasma cells
TERMINOLOGY
Abbreviations
•
Autoimmune pancreatitis (AIP)
Synonyms
•
Lymphoplasmacytic sclerosing pancreatitis (LPSP)
•
Idiopathic duct-centric chronic pancreatitis (IDCP)
•
Primary sclerosing pancreatitis
•
IgG4-related pancreatitis (type 1 only)
Definitions
•
Fibroinflammatory disease of presumed autoimmune etiology
Other organs can also be affected
•
Associated with many other autoimmune diseases
•
Specific antigenic trigger unknown
CLINICAL ISSUES
Presentation
•
Nonspecific: Jaundice, weight loss, abdominal pain, fatigue